Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

LOINC team’s nimble response provides help to track virus

LOINC®, a universal medical coding system maintained at Regenstrief Institute, has been a leader in fostering communication during the global COVID-19 pandemic. As the virus was first identified, the LOINC team created universal codes to identify lab tests and results related to SARS-CoV-2 and COVID-19. These codes are crucial to helping public health leaders track cases around the world.

LOINC (Logical Observation Identifiers Names and Codes) coordinated with the U.S. Centers for Disease Control and Prevention (CDC), public health and reference labs, and in vitro diagnostic manufacturers to create standardized terms to allow health organizations to collect and share results from testing for the virus.

In place of its regular committee meetings, LOINC is also hosting a virtual meeting on March 26 to focus on the use of SARS-CoV-2/COVID-19 codes. The response has been overwhelming. More than 600 people signed up to attend. If you are interested, you can sign up here through Tuesday, March 24.

This pandemic has shed light on the importance of health data interoperability. Each health system and clinic has its own method for categorizing health observations, such as lab tests and clinical documents. The different methods make it difficult for systems to exchange information. In times of crisis, such as the COVID-19 pandemic, having complete data on testing is crucial to understanding the situation and informing public health decisions.

“LOINC codes enable efficient transmission, understanding and, most importantly, use of health data,” said Swapna Abhyankar, M.D., interim director of content development and operations for LOINC. “In public health emergencies, the interoperability provided by LOINC arms public health officials with a more complete set of data from which to make their decisions. I am proud of the LOINC team for its agility and diligence in reacting to this situation and supporting care teams in tracking the virus.”

The COVID-19 terms are available on LOINC’s website.

Related Influence

Oct 07, 2020 • Influence
Evaluating the link between medications and dementia: Regenstrief researcher provides consultation
Regenstrief Institute research scientist Noll Campbell, PharmD, M.S., recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline. The results from the study, led by researchers at the University of California San Diego School of Medicine, were published in Neurology. The authors concluded that…
Continue Reading >
Oct 05, 2020 • Influence
The role of informatics and HIT in learning health systems
Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., led a discussion as part of a Learning Health System Leaders Webinar Series put on by the Northwest Learning Health Systems Center of Excellence and K12. Dr. Embí discussed how informatics and health information technology (HIT) can be leveraged in learning health systems (LHS).  Dr. Embí shared his personal experience as a patient and explained the ways…
Continue Reading >